MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, CCCC has $265,488K in assets. $111,080K in debts. $58,809K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
575.50%
Cash Ratio
163.61%
Debt to Asset Ratio
41.84%
Assets Breakdown
    • Marketable securities, current
    • Cash and cash equivalents
    • Right-of-use asset
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liability, net o...
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
58,809 78,157
Marketable securities, current
133,075 136,397
Accounts receivable
6,542 2,158
Prepaid expenses and other current assets
8,438 8,017
Total current assets
206,864 224,729
Marketable securities, non-current
7,875 8,419
Property and equipment, net
5,134 5,540
Right-of-use asset
41,961 54,218
Restricted cash
3,443 3,443
Other assets
211 178
Total assets
265,488 296,527
Accounts payable
1,333 2,216
Accrued expenses and other current liabilities
11,270 13,554
Deferred revenue, current
17,126 22,620
Operating lease liability, current
6,216 6,066
Total current liabilities
35,945 44,456
Deferred revenue, net of current
19,888 21,150
Operating lease liability, net of current
55,247 56,857
Total liabilities
111,080 122,463
Common stock, par value of 0.0001 per share 300,000,000 and 150,000,000 shares authorized as of september30, 2025, and december31, 2024, respectively, and 74,174,515 and 70,625,899 shares issued and outstanding as of september30, 2025 and december31, 2024, respectively
7 7
Additional paid-in capital
872,521 860,128
Accumulated other comprehensive income
87 -30
Accumulated deficit
-718,207 -686,041
Total stockholders equity
154,408 174,064
Total liabilities and stockholders equity
265,488 296,527
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Prepaid expenses andother current assets$8,438K Accounts receivable$6,542K Marketable securities,current$133,075K Cash and cashequivalents$58,809K Other assets$211K Restricted cash$3,443K Right-of-use asset$41,961K Property and equipment,net$5,134K Marketable securities,non-current$7,875K Total current assets$206,864K Total assets$265,488K Total liabilities andstockholders equity$265,488K Total stockholdersequity$154,408K Total liabilities$111,080K Accumulated deficit-$718,207K Accumulated othercomprehensive income$87K Additional paid-in capital$872,521K Operating leaseliability, net of current$55,247K Deferred revenue, net ofcurrent$19,888K Total currentliabilities$35,945K Common stock, par valueof 0.0001 per share...$7K Operating leaseliability, current$6,216K Deferred revenue,current$17,126K Accrued expenses andother current...$11,270K Accounts payable$1,333K

C4 Therapeutics, Inc. (CCCC)

C4 Therapeutics, Inc. (CCCC)